Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer stem cells: lessons from leukemia.

Jean C Y Wang1, John E Dick

  • 1Division of Cell and Molecular Biology, University Health Network, and Department of Molecular and Medical Genetics, University of Toronto, 620 University Ave, Toronto, Ontario, M5G 2C1, Canada.

Trends in Cell Biology
|August 9, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia.

Leukemia·2026
Same author

Ex vivo expansion of hematopoietic stem and progenitor cells from human mobilized peripheral blood for gene therapy applications.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Human haematopoietic stem cells remember inflammatory stress.

Nature·2026
Same author

ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Transposable elements shape stemness in normal and leukemic hematopoiesis.

Nature genetics·2026
Same author

JAK2V617F reprograms Hypoxia Inducible Factor-1 to induce a non-canonical hypoxia regulon in myeloproliferative neoplasms.

Leukemia·2026
Same journal

Horizontal transfer of mitochondria in cancer: The physiology reborn in disease?

Trends in cell biology·2026
Same journal

Spindle errors: A stress test for epithelial robustness.

Trends in cell biology·2026
Same journal

Multicellular ecosystems: Linking cellular diversity to tissue function and disease.

Trends in cell biology·2026
Same journal

Orchestrating the signaling-bias at the protease-activated receptor, PAR1.

Trends in cell biology·2026
Same journal

Crashing by design: Utilizing DNA damage for MCC differentiation.

Trends in cell biology·2026
Same journal

The value of a shared lab: Our insights.

Trends in cell biology·2026
See all related articles

Identifying cancer stem cells (CSCs) is key to understanding tumor growth. Research now shows CSCs exist in solid tumors, crucial for developing targeted cancer therapies.

Area of Science:

  • Oncology
  • Cancer Biology
  • Stem Cell Research

Background:

  • The identification of cancer stem cells (CSCs) is a critical challenge in cancer research.
  • CSCs are defined as the cell type responsible for initiating and sustaining tumor growth.
  • While proposed over 40 years ago, CSCs have only recently been identified and characterized in hematological malignancies.

Purpose of the Study:

  • To review the identification and characterization of CSCs in various cancers.
  • To highlight the potential role of CSCs in solid tumors like breast and brain cancers.
  • To emphasize the importance of understanding CSC biology for cancer research and therapy development.

Main Methods:

  • Review of recent scientific literature on cancer stem cells.

Related Experiment Videos

  • Analysis of studies identifying and characterizing CSCs in hematological and solid tumors.
  • Synthesis of findings regarding the biological distinctness and therapeutic implications of CSCs.
  • Main Results:

    • CSCs have been identified and characterized in hematological malignancies.
    • Recent studies report the presence of CSCs in solid tumors, including breast and brain cancers.
    • This suggests CSCs may be fundamental to all neoplastic systems.

    Conclusions:

    • Understanding the unique biology of CSCs is essential for advancing cancer research.
    • Targeting CSCs holds promise for developing more effective and specific cancer therapies.
    • Further investigation into CSCs is crucial for improving patient treatment outcomes.